Mondelez International has opened a new R.&D. technical center in Wroclaw, Poland. The facility is specially designed to develop new products and technologies across all of the company’s brands, including Oreo, belVita and Milka.
The Wroclaw facility is the latest of nine previously-announced R.&D. hubs Mondelez plans to build by 2018. Four other technical centers already exist in East Hanover and Curitiba, Brazil, as well as Bournville and Reading in the U.K. The company plans to open centers in Mexico, China, India and Singapore by 2018. The project is expected to total $65 million.
Rob Hargrove, Mondelez
Rob Hargrove, executive vice-president of research, development, quality and innovation for Mondelez
“With these advantaged technical centers, we’re focusing our investment in research, equipment and capabilities, driving innovation to support our growth strategy, margin and quality platforms,” said Rob Hargrove, executive vice-president, research, development, quality and innovation. “These R.&D. hubs will improve speed, efficiency and effectiveness, while increased scale will enable us to more quickly address evolving consumer needs.”
This Wroclaw facility will house a diverse group of nearly 250 scientists, engineers and other specialists from many different countries. In addition to innovation labs and a large pilot plant, the site contains what the company calls a “collaboration kitchen.” The 102,250-square-foot space exists for employees to experiment with new ideas and formulations.
“Poland is one of our most important markets in Central Europe, and Wroclaw is a modern city that’s open to investment,” Mr. Hargrove said regarding the company’s latest site selection. “Embedding one of our largest technical centers here clearly signals the importance of Poland and Europe within our global R.&D. network.”
By Matt Hamer
Source: Food Business News
Cécile Béliot has assumed the role of Bel Group chief executive officer, following the decision to separate the roles of chairman and CEO. The separation of the functions will enable Bel Group to develop in three areas of healthy snacking. Meanwhile, the company’s former CEO, Antoine Fiévet, has had his mandate renewed as chairman of the board.
US Food and Drug Administration (FDA) Commissioner Dr. Robert Califf was grilled by lawmakers during a House Appropriations subcommittee hearing, where he was slammed over the agency’s handling of the escalating infant formula shortage.
Sweegen is ramping up its efforts to reduce sugar across F&B applications while simultaneously tapping into the benefits of using antioxidants and bitter blocking technology. Speaking to FoodIngredientsFirst, Casey McCormick, vice president of global innovation at Sweegen, says product developers can find a broad range of solutions in Sweegen’s nature-based sweetener systems as brands elevate better-for-you foods.